Please find all related articles below.
**Updated: the resolution will be discussed at the World Health Assembly in May 2006** On November 16 2005, the Republic of Kenya asked the World Health Organisation (WHO) to discuss a proposed resolution on a "Global Framework on Essential Health Research and Development" at the 23-28 January meeting of the WHO’s Executive Board.
The resolution is a really strategic and important opportunity to get support for a new global framework for health Research & Development which (...)
Mrs Felicity PORRITT
Policy and Outreach Manager
19 Harley Street, First Floor
UK-W1G 9QJ LONDON
Phone +44 207 3434266
Fax +44 207 3434220
Recently, the European Commission published two calls for proposals in the area of Science and Society under the Sixth Framework Programme.
The objective of the call is to contribute to universities’ mission of sharing knowledge outside the academic sphere. It mainly targets local civil society, universities and organisations involved in the training of students.
The call requires the use of specific support actions (SSA) and coordination actions (CA). Participants (...)
The European AIDS Treatment Group (EATG), an EPHA member organisation, issued their position paper on clinical research and drug users in order to urge key stakeholders to include drug users in the clinical trials.
Despite the high prevalence of HIV/AIDS within the injecting drug user population, EATG points out that drug users are excluded from clinical trials which raise concerns regarding the relevance of future treatments for this high-risk population.
EATG notes that health care (...)
EPHA Member, the European Federation of Allergy and Airways Diseases Patients’ Association (EFA) launched the results of the survey "Fighting for Breath: a European patient perspective on severe asthma" at the European Respiratory Society (ERS) Congress in September 2005.
Up until now, no pan-European survey by patients for patients has reported the real life experiences of what people living with severe asthma undergo every day. According to the report, "millions of people across (...)
The first results of a three-year project aimed to evaluate the links between reported healthcare expenditures and the use of medical services were presented by the European Network of Economic Policy Research Institutes (ENEPRI) and the Center for European Policy Studies (CEPS).
Entitled AHEAD (Ageing, Health Status and Determinants of Health Expenditure), the project’s main objectives are:
to assess factors that trigger health spending in the EU, with a particular focus on (...)
The European Consumers’ Organisation (BEUC) conducted a survey on European consumers’ perception of foodstuffs labelling, revealing the effectiveness of nutritional claims in attracting consumers’ attention and influencing their purchase.
BEUC’s study attempts to evaluate the different factors that influence a consumer when buying foodstuff. The interest in nutrition, the sources of information, the nutritional knowledge, understanding and perception and (...)
Sponsored by the Member of the Europea Parliament (MEP) Ursula Stenzel (EPP- AU), EULAR - the European League Against Rheumatism - organised a conference in the European Parliament. They asked MEPs to consider rheumatism as a major disease in the future FP7, which will allow rheumatic disease to benefit from a special budget line.
After a video message from the Commissioner for Research, Janez Potocnik, 8 speakers (including 2 speakers from pharmaceutical companies) repeated the need to (...)
This article has been updated with the Council’s position and the second reading from the European Parliament.
The European Parliament voted on 7 September in favour of a European Commission Directive to guarantee that medicines administered to children are actually suitable for them. An overwhelming majority of MEPs supported this way the stimulation of research into development of paediatric medicines in Europe.
The Parliament’s decision will now go to the Council, where the (...)
A new European Commission report on biotechnology inventions refuses to take a clear position on the patenting of human stem cells.
This highly controversial issue covers the protection of biotechnology inventions and a potentially lucrative and large market, but also the ethical aspects of patenting.
These ethical concerns have been at the heart of a 10 year stand-off between EU governments and MEPs that was ended by the adoption of a Directive and a European Court of Justice ruling (...)